New Leaf Venture Partners, L.L.C. Sage Therapeutics, Inc. Transaction History

New Leaf Venture Partners, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $3.8 Million - $4.81 Million	-25,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $1.21 Million - $3.33 Million	-19,872 Reduced 44.29%	25,000 $4.12 Million
Q3 2017 Nov 14, 2017	SELL	$61.4 - $88.52 $1.41 Million - $2.04 Million	-23,000 Reduced 33.89%	44,872 $2.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	67,872	67,872 $5.41 Million

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.